Penumbra, Inc. (PEN) Tops Q4 EPS by 6c, Guides FY Revenue In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Penumbra, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
February 26, 2019 4:05 PM ESTALAMEDA, Calif., Feb. 26, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2018.
Financial Highlights:
Revenue of $120.8 million for the fourth quarter of 2018, an increase of 25.8%, or 26.9% in constant currency1,... More